CN102247541A - Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma - Google Patents
Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma Download PDFInfo
- Publication number
- CN102247541A CN102247541A CN2010105960875A CN201010596087A CN102247541A CN 102247541 A CN102247541 A CN 102247541A CN 2010105960875 A CN2010105960875 A CN 2010105960875A CN 201010596087 A CN201010596087 A CN 201010596087A CN 102247541 A CN102247541 A CN 102247541A
- Authority
- CN
- China
- Prior art keywords
- parts
- asthma
- rheumatism
- radix
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatome. The medicament comprises Mythic Fungus, ginseng, epimedium, Radix Astragali, Rhizoma Polygoni Cuspidati, rhizoma gastrodiae, cordate houttuynia, and licorice. The medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma which is prepared from pure traditional Chinese medicines has the advantages of good treatment effect, less side effect, short treatment course and the like, can simultaneously treat various diseases, has the efficacies of antibiosis and antiphlogosis, cough and asthma relieving, blood pressure and sugar reduction, calmness and tranquillization, blood circulation invigoration and pain relieving, virus killing, and human body immunity improvement, and has the effects of treating tumors, prolonging life span and preventing aging.
Description
[technical field]
The present invention relates to a kind of pharmaceutical formulation, relate in particular to a kind of medicine that can treat multiple treatment of diseases liver-kidney diseases, diabetes, asthma, rheumatism, cutaneous tumor simultaneously.
[background technology]
In process is cured the disease in present clinical application, generally all be based on the single relatively medicine of function, can not satisfy the requirement of the multiple disease of treatment.And because existing medicine a multitude of names, general patient is difficult to select the medicine treatment according to self disease oneself.
In addition, it is Western medicine greatly that existing medicine has, and not only the expense costliness makes general ordinary people be difficult to bear, and has toxic and side effects usually, and patient takes for a long time or in a large number and can cause human body viscera damage and develop immunity to drugs, thoroughly radical curing of disease.Some people also can produce the phenomenon of vomiting when taking Western medicine, thereby has increased patient's misery.
In this case, people turn to the traditional Chinese medical science to the hope of treatment.Yet, the medicine that still unmatchful multiple disease can be treated simultaneously in the present traditional Chinese medical science.
Therefore, for avoiding the problems referred to above, necessaryly provide a kind of medicine for the treatment of liver-kidney diseases, diabetes, asthma, rheumatism, cutaneous tumor, to overcome described defective of the prior art.
[summary of the invention]
For addressing the above problem, the object of the present invention is to provide a kind of therapeutic effect good, side effect is little, short treating period, and can treat the medicine of multiple treatment of diseases liver-kidney diseases, diabetes, asthma, rheumatism, cutaneous tumor simultaneously.
For achieving the above object, the technical scheme that the present invention takes is: a kind of medicine for the treatment of liver-kidney diseases, diabetes, asthma, rheumatism, cutaneous tumor, it comprises Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, Herba Houttuyniae and Radix Glycyrrhizae.
The medicine of treatment liver-kidney diseases of the present invention, diabetes, asthma, rheumatism, cutaneous tumor further is: described Ganoderma, and Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 10～14 parts of Ganodermas; 7～9 parts of Radix Ginsengs; 15～20 parts of Herba Epimedii; 9～11 parts of the Radixs Astragali; 10～12 parts of Rhizoma Polygoni Cuspidati; 6～8 parts in Rhizoma Gastrodiae; 11～15 parts of Herba Houttuyniae; 11～15 parts in Radix Glycyrrhizae.
The medicine of treatment liver-kidney diseases of the present invention, diabetes, asthma, rheumatism, cutaneous tumor further is: described Ganoderma, and Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts in Rhizoma Gastrodiae; 12 parts of Herba Houttuyniae; 12 parts in Radix Glycyrrhizae.
The medicine of treatment liver-kidney diseases of the present invention, diabetes, asthma, rheumatism, cutaneous tumor can also for: described pharmaceutical formulation can be made tablet, capsule, electuary, oral liquid or injection.
Compared with prior art, the present invention has following beneficial effect: the medicine of treatment liver-kidney diseases of the present invention, diabetes, asthma, rheumatism, cutaneous tumor is that pure Chinese medicine is made, and it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; Simultaneously, this pharmaceutical formulation can be treated multiple disease simultaneously, has anti-inflammation, relieving cough and relieving asthma, and reducing pressure and sugar, tranquillizing and allaying excitement, promoting blood circulation and stopping pain, kill virus, the effect of raising body immunity is treated tumor, the anti-aging effect of life lengthening in addition.
[specific embodiment]
The present invention is described further below in conjunction with embodiment.
Embodiment 1:
The medicine of treatment liver-kidney diseases of the present invention, diabetes, asthma, rheumatism, cutaneous tumor is made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, Herba Houttuyniae and Radix Glycyrrhizae.Wherein, described Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 10～14 parts of Ganodermas; 7～9 parts of Radix Ginsengs; 15～20 parts of Herba Epimedii; 9～11 parts of the Radixs Astragali; 10～12 parts of Rhizoma Polygoni Cuspidati; 6～8 parts in Rhizoma Gastrodiae; 11～15 parts of Herba Houttuyniae; 11～15 parts in Radix Glycyrrhizae.Described pharmaceutical formulation is made tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
Embodiment 2:
The medicine of treatment liver-kidney diseases of the present invention, diabetes, asthma, rheumatism, cutaneous tumor is made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, Herba Houttuyniae and Radix Glycyrrhizae.Wherein, described Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts in Rhizoma Gastrodiae; 12 parts of Herba Houttuyniae; 12 parts in Radix Glycyrrhizae.Described pharmaceutical formulation is made tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
The medicine of treatment liver-kidney diseases of the present invention, diabetes, asthma, rheumatism, cutaneous tumor is that pure Chinese medicine is made, and it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; Simultaneously, this pharmaceutical formulation can be treated multiple disease simultaneously, has anti-inflammation, relieving cough and relieving asthma, and reducing pressure and sugar, tranquillizing and allaying excitement, promoting blood circulation and stopping pain, kill virus, the effect of raising body immunity is treated tumor, the anti-aging effect of life lengthening in addition.
The above specific embodiment only is the preferred embodiment of this creation, not in order to limiting this creation, all in this creation spirit and principle within made any modification, be equal to replacement, improvement etc., all should be included within the protection domain of this creation.
Claims (4)
1. a medicine for the treatment of liver-kidney diseases, diabetes, asthma, rheumatism, cutaneous tumor is characterized in that: comprise Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, Herba Houttuyniae and Radix Glycyrrhizae.
2. the medicine of treatment liver-kidney diseases as claimed in claim 1, diabetes, asthma, rheumatism, cutaneous tumor is characterized in that: described Ganoderma, and Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented):
10～14 parts of Ganodermas;
7～9 parts of Radix Ginsengs;
15～20 parts of Herba Epimedii;
9～11 parts of the Radixs Astragali;
10～12 parts of Rhizoma Polygoni Cuspidati;
6～8 parts in Rhizoma Gastrodiae;
11～15 parts of Herba Houttuyniae;
11～15 parts in Radix Glycyrrhizae.
3. the medicine of treatment liver-kidney diseases as claimed in claim 2, diabetes, asthma, rheumatism, cutaneous tumor is characterized in that: described Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Rhizoma Polygoni Cuspidati, Rhizoma Gastrodiae, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Rhizoma Polygoni Cuspidati; 7 parts in Rhizoma Gastrodiae; 12 parts of Herba Houttuyniae; 12 parts in Radix Glycyrrhizae.
4. the medicine of treatment liver-kidney diseases as claimed in claim 3, diabetes, asthma, rheumatism, cutaneous tumor is characterized in that: described pharmaceutical formulation can be made tablet, capsule, electuary, oral liquid or injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105960875A CN102247541A (en) | 2010-12-20 | 2010-12-20 | Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105960875A CN102247541A (en) | 2010-12-20 | 2010-12-20 | Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102247541A true CN102247541A (en) | 2011-11-23 |
Family
ID=44975345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105960875A Pending CN102247541A (en) | 2010-12-20 | 2010-12-20 | Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102247541A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247542A (en) * | 2010-12-23 | 2011-11-23 | 陈玉堂 | Medicine for treating diabetes and kidney disease, cataract and other diabetic complications |
| CN102327492A (en) * | 2010-12-23 | 2012-01-25 | 陈玉堂 | Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury |
| CN102327491A (en) * | 2010-12-23 | 2012-01-25 | 陈玉堂 | Medicine for treating venereal diseases, such as prostatosis, condyloma acuminatum, gonorrhea syphilis and aids |
| CN102327493A (en) * | 2010-12-23 | 2012-01-25 | 陈玉堂 | Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases |
| CN102343041A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Medicine for treating rheumatism, gout, hyperosteogeny, femoral head necrosis, and lumber vertebral diseases |
| CN102343042A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus |
| CN102343039A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like |
| CN102343036A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Medicine for treating dysmenorrhoea, abnormal menstruation, impotence, premature ejaculation, and sterility infertility |
| CN102343037A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay |
-
2010
- 2010-12-20 CN CN2010105960875A patent/CN102247541A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102343041A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Medicine for treating rheumatism, gout, hyperosteogeny, femoral head necrosis, and lumber vertebral diseases |
| CN102343042A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus |
| CN102343039A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like |
| CN102343036A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Medicine for treating dysmenorrhoea, abnormal menstruation, impotence, premature ejaculation, and sterility infertility |
| CN102343037A (en) * | 2010-12-21 | 2012-02-08 | 陈玉堂 | Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay |
| CN102247542A (en) * | 2010-12-23 | 2011-11-23 | 陈玉堂 | Medicine for treating diabetes and kidney disease, cataract and other diabetic complications |
| CN102327492A (en) * | 2010-12-23 | 2012-01-25 | 陈玉堂 | Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury |
| CN102327491A (en) * | 2010-12-23 | 2012-01-25 | 陈玉堂 | Medicine for treating venereal diseases, such as prostatosis, condyloma acuminatum, gonorrhea syphilis and aids |
| CN102327493A (en) * | 2010-12-23 | 2012-01-25 | 陈玉堂 | Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102247541A (en) | Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma | |
| CN102078526A (en) | Medicament for treating hiccup | |
| CN106963811A (en) | A kind of draft liquid with promoting blood circulation, removing blood stasis and relieving pain | |
| CN102697868A (en) | Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis | |
| CN102697898A (en) | Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia | |
| CN103893559A (en) | Traditional Chinese medicinal drop for treating rhinitis and preparation method thereof | |
| CN101933963B (en) | Nasal in-situ gel for treating headache | |
| CN103405719A (en) | Medicament for treatment of depression | |
| CN102343038A (en) | Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like | |
| CN102018885A (en) | Chinese medicinal preparation for increasing immunity of organism | |
| CN105056055A (en) | Medicine for treating cough | |
| CN102327493A (en) | Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases | |
| CN102343042A (en) | Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus | |
| CN102343039A (en) | Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like | |
| CN104257795A (en) | Medicine for treating cold | |
| CN103405602A (en) | Medicament for treating asthma | |
| CN102343037A (en) | Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay | |
| CN102343040A (en) | Drug for treating otitis media, deaf and tinnitus | |
| CN102327492A (en) | Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury | |
| CN101700373B (en) | Traditional Chinese medicine used for smoking cessation | |
| CN103127255B (en) | Antioxidant externally-applied Chinese medicine dressing formula for treating asthma and preparation method thereof | |
| CN102327491A (en) | Medicine for treating venereal diseases, such as prostatosis, condyloma acuminatum, gonorrhea syphilis and aids | |
| CN102343036A (en) | Medicine for treating dysmenorrhoea, abnormal menstruation, impotence, premature ejaculation, and sterility infertility | |
| CN104258308A (en) | Traditional Chinese medicine preparation for treating cholelithiasis | |
| CN102247542A (en) | Medicine for treating diabetes and kidney disease, cataract and other diabetic complications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111123 |